

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.32327563 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.32327563 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.07869574 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.07869574 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.65286437 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.19346291 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.11288700 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.07588449 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.07588449 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.07588449 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.93510855 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.90038720 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.71377885 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.65391283 |
| 15 | cysteine metabolic process (GO:0006534) | 5.58477017 |
| 16 | urea cycle (GO:0000050) | 5.57424353 |
| 17 | urea metabolic process (GO:0019627) | 5.57424353 |
| 18 | angiotensin maturation (GO:0002003) | 5.54713505 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.47390664 |
| 20 | proline metabolic process (GO:0006560) | 5.40388790 |
| 21 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.39717920 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.35904315 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.28514365 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.23994729 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 5.16587796 |
| 26 | intestinal absorption (GO:0050892) | 5.13394795 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.12805944 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.06990854 |
| 29 | lysine metabolic process (GO:0006553) | 5.06488299 |
| 30 | lysine catabolic process (GO:0006554) | 5.06488299 |
| 31 | protein carboxylation (GO:0018214) | 5.00084400 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.00084400 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.99170030 |
| 34 | proline biosynthetic process (GO:0006561) | 4.98950585 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.96302678 |
| 36 | regulation of protein activation cascade (GO:2000257) | 4.95039803 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.91844506 |
| 38 | bile acid metabolic process (GO:0008206) | 4.86673879 |
| 39 | NADH metabolic process (GO:0006734) | 4.86234261 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.84352221 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.83933807 |
| 42 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.83901097 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.80174180 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.75252348 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.73375460 |
| 46 | drug metabolic process (GO:0017144) | 4.65769038 |
| 47 | regulation of complement activation (GO:0030449) | 4.62329134 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.60381226 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.60381226 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.60381226 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.57957826 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 4.57403019 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.57403019 |
| 54 | tyrosine metabolic process (GO:0006570) | 4.53757462 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.52487808 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.52487808 |
| 57 | phospholipid efflux (GO:0033700) | 4.52332504 |
| 58 | diacylglycerol metabolic process (GO:0046339) | 4.46665079 |
| 59 | plasma lipoprotein particle organization (GO:0071827) | 4.46143281 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.42729466 |
| 61 | drug catabolic process (GO:0042737) | 4.37569289 |
| 62 | fructose metabolic process (GO:0006000) | 4.33086276 |
| 63 | glycine metabolic process (GO:0006544) | 4.32441319 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 4.32168180 |
| 65 | glutamate metabolic process (GO:0006536) | 4.29188579 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.28320147 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.27796397 |
| 68 | cellular glucuronidation (GO:0052695) | 4.27773153 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.24862601 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 4.23089310 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 4.20169783 |
| 72 | coenzyme catabolic process (GO:0009109) | 4.17046351 |
| 73 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.15918255 |
| 74 | benzene-containing compound metabolic process (GO:0042537) | 4.14528940 |
| 75 | amine catabolic process (GO:0009310) | 4.14351831 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 4.14351831 |
| 77 | protein-lipid complex subunit organization (GO:0071825) | 4.11040483 |
| 78 | drug transmembrane transport (GO:0006855) | 4.10017201 |
| 79 | cholesterol efflux (GO:0033344) | 4.09994952 |
| 80 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.07809440 |
| 81 | regulation of cholesterol metabolic process (GO:0090181) | 4.07477681 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 4.07398127 |
| 83 | ethanol oxidation (GO:0006069) | 4.03006222 |
| 84 | urate metabolic process (GO:0046415) | 4.01100588 |
| 85 | ethanol metabolic process (GO:0006067) | 4.00937257 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98458863 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 3.98413582 |
| 88 | imidazole-containing compound metabolic process (GO:0052803) | 3.95784396 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.92515391 |
| 90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.92515391 |
| 91 | arginine metabolic process (GO:0006525) | 3.90932577 |
| 92 | regulation of cholesterol homeostasis (GO:2000188) | 3.86932301 |
| 93 | aldehyde catabolic process (GO:0046185) | 3.86574489 |
| 94 | glucuronate metabolic process (GO:0019585) | 3.83665119 |
| 95 | uronic acid metabolic process (GO:0006063) | 3.83665119 |
| 96 | ketone body metabolic process (GO:1902224) | 3.82368669 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.80995595 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.78612372 |
| 99 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76136068 |
| 100 | lipoprotein transport (GO:0042953) | 3.76115852 |
| 101 | aspartate family amino acid catabolic process (GO:0009068) | 3.74716023 |
| 102 | omega-hydroxylase P450 pathway (GO:0097267) | 3.74709949 |
| 103 | exogenous drug catabolic process (GO:0042738) | 3.74499341 |
| 104 | acetyl-CoA metabolic process (GO:0006084) | 3.74335119 |
| 105 | sterol homeostasis (GO:0055092) | 3.74152515 |
| 106 | carboxylic acid catabolic process (GO:0046395) | 3.74129902 |
| 107 | organic acid catabolic process (GO:0016054) | 3.74129902 |
| 108 | fibrinolysis (GO:0042730) | 3.73985361 |
| 109 | phospholipid homeostasis (GO:0055091) | 3.73075709 |
| 110 | flavonoid metabolic process (GO:0009812) | 3.72631778 |
| 111 | low-density lipoprotein particle remodeling (GO:0034374) | 3.67920215 |
| 112 | positive regulation of lipid catabolic process (GO:0050996) | 3.66240174 |
| 113 | response to nitrosative stress (GO:0051409) | 3.63840859 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.63811895 |
| 115 | intestinal cholesterol absorption (GO:0030299) | 3.61986072 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.60783583 |
| 117 | blood coagulation, intrinsic pathway (GO:0007597) | 3.60097294 |
| 118 | lipoprotein metabolic process (GO:0042157) | 3.57215381 |
| 119 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.56881634 |
| 120 | cofactor catabolic process (GO:0051187) | 3.56492733 |
| 121 | hormone catabolic process (GO:0042447) | 3.55928895 |
| 122 | 2-oxoglutarate metabolic process (GO:0006103) | 3.55247903 |
| 123 | alkaloid metabolic process (GO:0009820) | 3.53214237 |
| 124 | vitamin transmembrane transport (GO:0035461) | 3.43863718 |
| 125 | oxidative demethylation (GO:0070989) | 3.34025744 |
| 126 | regulation of plasminogen activation (GO:0010755) | 3.28453187 |
| 127 | drug transport (GO:0015893) | 3.26246862 |
| 128 | oxaloacetate metabolic process (GO:0006107) | 3.26143332 |
| 129 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.21615785 |
| 130 | complement activation, classical pathway (GO:0006958) | 3.20913125 |
| 131 | vitamin biosynthetic process (GO:0009110) | 3.17196578 |
| 132 | peptide catabolic process (GO:0043171) | 3.16835335 |
| 133 | L-ascorbic acid metabolic process (GO:0019852) | 3.14271862 |
| 134 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.13419871 |
| 135 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.12896651 |
| 136 | endocrine process (GO:0050886) | 3.12896651 |
| 137 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.12896651 |
| 138 | negative regulation of hemostasis (GO:1900047) | 3.08557313 |
| 139 | negative regulation of blood coagulation (GO:0030195) | 3.08557313 |
| 140 | primary alcohol catabolic process (GO:0034310) | 3.00609553 |
| 141 | protein activation cascade (GO:0072376) | 3.00281151 |
| 142 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.00233612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.29857054 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20909998 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.67242233 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42126608 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.10755978 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.94106145 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.86876065 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97765946 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89221782 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.22047073 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.18522522 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11550580 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10239668 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.09872538 |
| 15 | P68_20966046_ChIP-Seq_HELA_Human | 2.02282164 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7379477 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 1.84211203 |
| 18 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82695008 |
| 19 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.74454022 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65593375 |
| 21 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.64047603 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63287929 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.61032667 |
| 24 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.56685724 |
| 25 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.56680782 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51713130 |
| 27 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.51223188 |
| 28 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.48214460 |
| 29 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43973311 |
| 30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.41650115 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37076434 |
| 32 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34771537 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34560225 |
| 34 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.33602689 |
| 35 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27540347 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27213030 |
| 37 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26974187 |
| 38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26811145 |
| 39 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.24492224 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24286309 |
| 41 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.24000696 |
| 42 | SA1_27219007_Chip-Seq_Bcells_Human | 1.23561718 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21803815 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19774220 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19143999 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19037970 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18964417 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18029453 |
| 49 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17691588 |
| 50 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16007044 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15782491 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15342250 |
| 53 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.15338065 |
| 54 | P300_27268052_Chip-Seq_Bcells_Human | 1.12062676 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12052850 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10432857 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10080017 |
| 58 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.09534091 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09429275 |
| 60 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09256319 |
| 61 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08887000 |
| 62 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.06702801 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05996168 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04714208 |
| 65 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04321615 |
| 66 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.03675265 |
| 67 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03619903 |
| 68 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02904728 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02720290 |
| 70 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.02564634 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02291349 |
| 72 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02205935 |
| 73 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.02031844 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02028366 |
| 75 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01632478 |
| 76 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.01600655 |
| 77 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01272536 |
| 78 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99709797 |
| 79 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98510106 |
| 80 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97063971 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96916413 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96784868 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96306564 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94983486 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94440426 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88694452 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87412780 |
| 88 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84642149 |
| 89 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81094699 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80627182 |
| 91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79564312 |
| 92 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78789390 |
| 93 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78624585 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77519706 |
| 95 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77428777 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77100495 |
| 97 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76386948 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74671574 |
| 99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.72807079 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72688238 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72062220 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72050337 |
| 103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.71086114 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70608361 |
| 105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69988227 |
| 106 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69724262 |
| 107 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69195211 |
| 108 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.69088007 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66930712 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65143900 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.63185225 |
| 112 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61801352 |
| 113 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59841521 |
| 114 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55829997 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55354438 |
| 116 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54907829 |
| 117 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54453772 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53974629 |
| 119 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53885150 |
| 120 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52423641 |
| 121 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51768285 |
| 122 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51585797 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50520058 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.50417653 |
| 125 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49762823 |
| 126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48531701 |
| 127 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48215116 |
| 128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.47843154 |
| 129 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.47843154 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46665917 |
| 131 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46515035 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45338297 |
| 133 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.45334142 |
| 134 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45187900 |
| 135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45096919 |
| 136 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44790808 |
| 137 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.44676427 |
| 138 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44541835 |
| 139 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.44213228 |
| 140 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.43345164 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41822890 |
| 142 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.41388648 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.41252273 |
| 144 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.41071749 |
| 145 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.40792578 |
| 146 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.40411271 |
| 147 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40195090 |
| 148 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.40151175 |
| 149 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39950918 |
| 150 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.39723303 |
| 151 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.39404428 |
| 152 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.38281226 |
| 153 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.37957403 |
| 154 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37794105 |
| 155 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.37716504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.17867658 |
| 2 | MP0005360_urolithiasis | 8.12382848 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.15406289 |
| 4 | MP0005365_abnormal_bile_salt | 5.93462451 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02035490 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.99563726 |
| 7 | MP0003252_abnormal_bile_duct | 3.91826571 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.51615850 |
| 9 | MP0009840_abnormal_foam_cell | 3.32916837 |
| 10 | MP0005332_abnormal_amino_acid | 2.98631404 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.80388167 |
| 12 | MP0003195_calcinosis | 2.79598408 |
| 13 | MP0005083_abnormal_biliary_tract | 2.76527738 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.62969092 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.55107709 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.31394778 |
| 17 | MP0000609_abnormal_liver_physiology | 2.10803584 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.10051566 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.04510237 |
| 20 | MP0000566_synostosis | 1.91367419 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.83526414 |
| 22 | MP0003868_abnormal_feces_composition | 1.75261227 |
| 23 | MP0001764_abnormal_homeostasis | 1.62477449 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59435880 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.54975478 |
| 26 | MP0009379_abnormal_foot_pigmentation | 1.50775623 |
| 27 | MP0000678_abnormal_parathyroid_gland | 1.43420137 |
| 28 | MP0005451_abnormal_body_composition | 1.41266895 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.40852853 |
| 30 | MP0003011_delayed_dark_adaptation | 1.39810868 |
| 31 | MP0009697_abnormal_copulation | 1.39040106 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.38875242 |
| 33 | MP0004858_abnormal_nervous_system | 1.27793085 |
| 34 | MP0003186_abnormal_redox_activity | 1.26939790 |
| 35 | MP0001873_stomach_inflammation | 1.26684248 |
| 36 | MP0002089_abnormal_postnatal_growth/wei | 1.25625491 |
| 37 | MP0004147_increased_porphyrin_level | 1.23828832 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.20356028 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 1.17397276 |
| 40 | MP0000598_abnormal_liver_morphology | 1.16796960 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.12461533 |
| 42 | MP0005409_darkened_coat_color | 1.07745170 |
| 43 | MP0001664_abnormal_digestion | 1.06700822 |
| 44 | MP0002249_abnormal_larynx_morphology | 1.05432744 |
| 45 | MP0005647_abnormal_sex_gland | 1.00976675 |
| 46 | MP0003879_abnormal_hair_cell | 1.00973654 |
| 47 | MP0009764_decreased_sensitivity_to | 0.99838401 |
| 48 | MP0000604_amyloidosis | 0.99251993 |
| 49 | MP0002132_abnormal_respiratory_system | 0.97821755 |
| 50 | MP0002254_reproductive_system_inflammat | 0.96325155 |
| 51 | MP0003866_abnormal_defecation | 0.93478385 |
| 52 | MP0009763_increased_sensitivity_to | 0.92284635 |
| 53 | MP0002098_abnormal_vibrissa_morphology | 0.90018789 |
| 54 | MP0005084_abnormal_gallbladder_morpholo | 0.89635703 |
| 55 | MP0009642_abnormal_blood_homeostasis | 0.89265049 |
| 56 | MP0005670_abnormal_white_adipose | 0.88797320 |
| 57 | MP0000490_abnormal_crypts_of | 0.87216550 |
| 58 | MP0008469_abnormal_protein_level | 0.87143659 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 0.86256993 |
| 60 | MP0001756_abnormal_urination | 0.83985211 |
| 61 | MP0000477_abnormal_intestine_morphology | 0.80624461 |
| 62 | MP0002876_abnormal_thyroid_physiology | 0.80544939 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.76835921 |
| 64 | MP0001663_abnormal_digestive_system | 0.76795500 |
| 65 | MP0004043_abnormal_pH_regulation | 0.76313342 |
| 66 | MP0003123_paternal_imprinting | 0.76066158 |
| 67 | MP0005376_homeostasis/metabolism_phenot | 0.75565295 |
| 68 | MP0005408_hypopigmentation | 0.75107628 |
| 69 | MP0002136_abnormal_kidney_physiology | 0.73140773 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.72863638 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 0.72023269 |
| 72 | MP0010368_abnormal_lymphatic_system | 0.71544448 |
| 73 | MP0005501_abnormal_skin_physiology | 0.71098134 |
| 74 | MP0002971_abnormal_brown_adipose | 0.70509995 |
| 75 | MP0009053_abnormal_anal_canal | 0.69863030 |
| 76 | MP0005334_abnormal_fat_pad | 0.64508899 |
| 77 | MP0005266_abnormal_metabolism | 0.64465165 |
| 78 | MP0005535_abnormal_body_temperature | 0.64261208 |
| 79 | MP0001661_extended_life_span | 0.61503684 |
| 80 | MP0004185_abnormal_adipocyte_glucose | 0.61308988 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 0.60825036 |
| 82 | MP0003315_abnormal_perineum_morphology | 0.60651359 |
| 83 | MP0003329_amyloid_beta_deposits | 0.58735442 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 0.58713007 |
| 85 | MP0003878_abnormal_ear_physiology | 0.58713007 |
| 86 | MP0004130_abnormal_muscle_cell | 0.57670651 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 0.56649218 |
| 88 | MP0005448_abnormal_energy_balance | 0.56296618 |
| 89 | MP0004264_abnormal_extraembryonic_tissu | 0.53526518 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.52827429 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.52620559 |
| 92 | MP0002928_abnormal_bile_duct | 0.51554633 |
| 93 | MP0003690_abnormal_glial_cell | 0.51399667 |
| 94 | MP0002166_altered_tumor_susceptibility | 0.49378417 |
| 95 | MP0003638_abnormal_response/metabolism_ | 0.49168202 |
| 96 | MP0005395_other_phenotype | 0.48813820 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.48640463 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.48444350 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.47360748 |
| 100 | MP0005464_abnormal_platelet_physiology | 0.46841431 |
| 101 | MP0008260_abnormal_autophagy | 0.46464929 |
| 102 | MP0002822_catalepsy | 0.44884664 |
| 103 | MP0003122_maternal_imprinting | 0.43967766 |
| 104 | MP0002396_abnormal_hematopoietic_system | 0.43762201 |
| 105 | MP0003718_maternal_effect | 0.43347946 |
| 106 | MP0008873_increased_physiological_sensi | 0.42976290 |
| 107 | MP0002796_impaired_skin_barrier | 0.42866548 |
| 108 | MP0003953_abnormal_hormone_level | 0.42304138 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.41944816 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 0.37980485 |
| 111 | MP0009115_abnormal_fat_cell | 0.37578782 |
| 112 | MP0009672_abnormal_birth_weight | 0.37175304 |
| 113 | MP0005166_decreased_susceptibility_to | 0.37122283 |
| 114 | MP0000538_abnormal_urinary_bladder | 0.36470157 |
| 115 | MP0003300_gastrointestinal_ulcer | 0.36357368 |
| 116 | MP0008874_decreased_physiological_sensi | 0.36241111 |
| 117 | MP0008872_abnormal_physiological_respon | 0.35721747 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.35425047 |
| 119 | MP0003436_decreased_susceptibility_to | 0.35037873 |
| 120 | MP0002168_other_aberrant_phenotype | 0.34202195 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.34150066 |
| 122 | MP0003075_altered_response_to | 0.33505610 |
| 123 | MP0002135_abnormal_kidney_morphology | 0.32461091 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.31945280 |
| 125 | MP0002970_abnormal_white_adipose | 0.31076188 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.30829407 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.29704389 |
| 128 | MP0003724_increased_susceptibility_to | 0.29619036 |
| 129 | MP0000249_abnormal_blood_vessel | 0.28164231 |
| 130 | MP0006082_CNS_inflammation | 0.27621984 |
| 131 | MP0000579_abnormal_nail_morphology | 0.27421207 |
| 132 | MP0001243_abnormal_dermal_layer | 0.24666020 |
| 133 | MP0001881_abnormal_mammary_gland | 0.24369793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.00334902 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.83759158 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.77757237 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.39536596 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.24053922 |
| 6 | Xanthomatosis (HP:0000991) | 6.06934552 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.83401939 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.01219901 |
| 9 | Complement deficiency (HP:0004431) | 4.90649244 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.77476329 |
| 11 | Hyperammonemia (HP:0001987) | 4.62829105 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.60044908 |
| 13 | Hyperglycinemia (HP:0002154) | 4.38392052 |
| 14 | Ketosis (HP:0001946) | 4.36713190 |
| 15 | Joint hemorrhage (HP:0005261) | 4.34805470 |
| 16 | Hyperglycinuria (HP:0003108) | 4.33640530 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27994143 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22583299 |
| 19 | Epidermoid cyst (HP:0200040) | 4.17261415 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.16290329 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.16290329 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13675672 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06060304 |
| 24 | Fat malabsorption (HP:0002630) | 4.05493554 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.90275512 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.89575975 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.77695957 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.71071364 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.63286528 |
| 30 | Abnormality of complement system (HP:0005339) | 3.57591841 |
| 31 | Widely patent fontanelles and sutures (HP:0004492) | 3.55071819 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.49474518 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.46931008 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.45106196 |
| 35 | Abnormality of nucleobase metabolism (HP:0010932) | 3.42122724 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33336715 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.30129620 |
| 38 | Gout (HP:0001997) | 3.28381976 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 3.27648403 |
| 40 | Ketoacidosis (HP:0001993) | 3.27414511 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.10893649 |
| 42 | Confusion (HP:0001289) | 3.05204033 |
| 43 | Pigmentary retinal degeneration (HP:0001146) | 2.98827390 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.97681411 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.95883500 |
| 46 | Metabolic acidosis (HP:0001942) | 2.93715599 |
| 47 | Steatorrhea (HP:0002570) | 2.92286385 |
| 48 | Malnutrition (HP:0004395) | 2.84894314 |
| 49 | Cholecystitis (HP:0001082) | 2.80820090 |
| 50 | Abnormal gallbladder physiology (HP:0012438) | 2.80820090 |
| 51 | Vascular calcification (HP:0004934) | 2.76282492 |
| 52 | Spontaneous abortion (HP:0005268) | 2.71976168 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.71013819 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.71013819 |
| 55 | Myocardial infarction (HP:0001658) | 2.69796488 |
| 56 | Lethargy (HP:0001254) | 2.66827200 |
| 57 | Acanthocytosis (HP:0001927) | 2.66398584 |
| 58 | Hypochromic microcytic anemia (HP:0004840) | 2.60363709 |
| 59 | Thin bony cortex (HP:0002753) | 2.60359987 |
| 60 | Abnormal urine phosphate concentration (HP:0012599) | 2.60212338 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.58719828 |
| 62 | Skin nodule (HP:0200036) | 2.53649484 |
| 63 | Ileus (HP:0002595) | 2.53336148 |
| 64 | Wide cranial sutures (HP:0010537) | 2.51874877 |
| 65 | Proximal tubulopathy (HP:0000114) | 2.47596817 |
| 66 | Nausea (HP:0002018) | 2.46050154 |
| 67 | Spastic diplegia (HP:0001264) | 2.44875604 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.44381775 |
| 69 | Hypophosphatemia (HP:0002148) | 2.43948996 |
| 70 | Irritability (HP:0000737) | 2.43543149 |
| 71 | Abnormal gallbladder morphology (HP:0012437) | 2.42481095 |
| 72 | Nephritis (HP:0000123) | 2.42287173 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.41105427 |
| 74 | Increased purine levels (HP:0004368) | 2.40628466 |
| 75 | Hyperuricemia (HP:0002149) | 2.40628466 |
| 76 | Cholelithiasis (HP:0001081) | 2.40061456 |
| 77 | Potter facies (HP:0002009) | 2.40032691 |
| 78 | Facial shape deformation (HP:0011334) | 2.40032691 |
| 79 | Purpura (HP:0000979) | 2.39603361 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.38531358 |
| 81 | Late onset (HP:0003584) | 2.37840821 |
| 82 | Hydroxyprolinuria (HP:0003080) | 2.34579463 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.34579463 |
| 84 | Neonatal onset (HP:0003623) | 2.33399838 |
| 85 | Alkalosis (HP:0001948) | 2.31175986 |
| 86 | Hyperphosphaturia (HP:0003109) | 2.29866027 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.27383516 |
| 88 | Megaloblastic anemia (HP:0001889) | 2.26108050 |
| 89 | Cerebral edema (HP:0002181) | 2.26010665 |
| 90 | Enlarged kidneys (HP:0000105) | 2.25257607 |
| 91 | Flat acetabular roof (HP:0003180) | 2.24107589 |
| 92 | Vomiting (HP:0002013) | 2.22089025 |
| 93 | Mitral stenosis (HP:0001718) | 2.21994152 |
| 94 | Glomerulonephritis (HP:0000099) | 2.20674339 |
| 95 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.20448094 |
| 96 | Esophageal varix (HP:0002040) | 2.19836515 |
| 97 | Reticulocytosis (HP:0001923) | 2.18780598 |
| 98 | Pancreatitis (HP:0001733) | 2.18027128 |
| 99 | Abdominal distention (HP:0003270) | 2.17680801 |
| 100 | Rickets (HP:0002748) | 2.16491835 |
| 101 | Abnormality of urine glucose concentration (HP:0011016) | 2.14511231 |
| 102 | Glycosuria (HP:0003076) | 2.14511231 |
| 103 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.12396608 |
| 104 | Amyloidosis (HP:0011034) | 2.10396001 |
| 105 | Delayed epiphyseal ossification (HP:0002663) | 2.09717066 |
| 106 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08310622 |
| 107 | Increased serum ferritin (HP:0003281) | 2.05754697 |
| 108 | Abnormality of vitamin B metabolism (HP:0004340) | 2.04631867 |
| 109 | Brushfield spots (HP:0001088) | 2.04493057 |
| 110 | Abnormality of the gallbladder (HP:0005264) | 2.03720764 |
| 111 | Cerebral palsy (HP:0100021) | 2.02974712 |
| 112 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02859914 |
| 113 | Mucopolysacchariduria (HP:0008155) | 2.02859914 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.02072758 |
| 115 | Poikilocytosis (HP:0004447) | 1.99366100 |
| 116 | Opisthotonus (HP:0002179) | 1.99310737 |
| 117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96460261 |
| 118 | Hemorrhage of the eye (HP:0011885) | 1.96352104 |
| 119 | Thrombophlebitis (HP:0004418) | 1.96231768 |
| 120 | Menorrhagia (HP:0000132) | 1.95882865 |
| 121 | Prolonged neonatal jaundice (HP:0006579) | 1.95153713 |
| 122 | Elevated alkaline phosphatase (HP:0003155) | 1.94749150 |
| 123 | Abnormal cartilage morphology (HP:0002763) | 1.93961599 |
| 124 | Glomerulosclerosis (HP:0000096) | 1.93256299 |
| 125 | Abnormal hair laboratory examination (HP:0003328) | 1.93104199 |
| 126 | Focal segmental glomerulosclerosis (HP:0000097) | 1.92252442 |
| 127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92144093 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92144093 |
| 129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92144093 |
| 130 | Gingival bleeding (HP:0000225) | 1.91483854 |
| 131 | Vaginal fistula (HP:0004320) | 1.86569924 |
| 132 | Nephrolithiasis (HP:0000787) | 1.85824184 |
| 133 | Hypophosphatemic rickets (HP:0004912) | 1.83088586 |
| 134 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82812360 |
| 135 | Abnormality of vitamin metabolism (HP:0100508) | 1.82672277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.74264996 |
| 2 | ERN1 | 4.79436373 |
| 3 | FGFR4 | 4.32433552 |
| 4 | SIK1 | 3.92522053 |
| 5 | SMG1 | 3.24770320 |
| 6 | TAOK3 | 2.70165296 |
| 7 | ERBB4 | 2.61599990 |
| 8 | EEF2K | 2.51794048 |
| 9 | INSRR | 2.47079089 |
| 10 | MST1R | 2.46164036 |
| 11 | TESK2 | 2.27369400 |
| 12 | PKN2 | 2.16752129 |
| 13 | ACVR1B | 2.06302479 |
| 14 | TRIB3 | 2.02148859 |
| 15 | MAPKAPK3 | 1.96397786 |
| 16 | MAPK11 | 1.91304382 |
| 17 | MAP2K4 | 1.88231006 |
| 18 | FRK | 1.80039386 |
| 19 | LATS1 | 1.78286622 |
| 20 | PTK6 | 1.70601214 |
| 21 | FLT3 | 1.67301630 |
| 22 | WNK4 | 1.65645534 |
| 23 | GRK6 | 1.59611942 |
| 24 | PDK4 | 1.57383727 |
| 25 | PDK3 | 1.57383727 |
| 26 | MAP3K10 | 1.50021189 |
| 27 | TYK2 | 1.45545039 |
| 28 | STK38L | 1.41311565 |
| 29 | TLK1 | 1.33112446 |
| 30 | RPS6KB2 | 1.30600337 |
| 31 | PIK3CG | 1.30010729 |
| 32 | ABL2 | 1.27878019 |
| 33 | WNK3 | 1.27781429 |
| 34 | NEK9 | 1.23205572 |
| 35 | VRK2 | 1.18530490 |
| 36 | MAP3K7 | 1.17638380 |
| 37 | MAP3K3 | 1.14087276 |
| 38 | PRKAA2 | 1.11907397 |
| 39 | MATK | 1.11651616 |
| 40 | KDR | 1.11022293 |
| 41 | CDK7 | 1.07872762 |
| 42 | PIM2 | 1.07724361 |
| 43 | PRKD2 | 1.07466299 |
| 44 | DAPK2 | 1.05783971 |
| 45 | DYRK1B | 1.04020038 |
| 46 | ICK | 1.03916318 |
| 47 | JAK2 | 1.03810856 |
| 48 | PINK1 | 1.02323552 |
| 49 | CDK12 | 1.01382969 |
| 50 | TBK1 | 1.01274021 |
| 51 | EIF2AK1 | 1.00595161 |
| 52 | MAP3K11 | 1.00266490 |
| 53 | MAP2K3 | 0.98794245 |
| 54 | NME2 | 0.98206780 |
| 55 | NME1 | 0.97146511 |
| 56 | RIPK1 | 0.96861409 |
| 57 | TYRO3 | 0.93852287 |
| 58 | MET | 0.93835895 |
| 59 | ERBB2 | 0.93354564 |
| 60 | FGFR2 | 0.92713489 |
| 61 | EPHB1 | 0.91577721 |
| 62 | TAOK1 | 0.90276732 |
| 63 | PRKCZ | 0.86912757 |
| 64 | PRKCI | 0.86697005 |
| 65 | MAPK4 | 0.85702819 |
| 66 | TNK2 | 0.85383152 |
| 67 | MAPK15 | 0.84413443 |
| 68 | OXSR1 | 0.83846202 |
| 69 | RIPK4 | 0.83158504 |
| 70 | PDK2 | 0.81819211 |
| 71 | GSK3A | 0.80479589 |
| 72 | MAP2K6 | 0.80037297 |
| 73 | MAP3K14 | 0.79017967 |
| 74 | PTK2 | 0.78641239 |
| 75 | CDK6 | 0.78215328 |
| 76 | PRKAA1 | 0.77088934 |
| 77 | JAK1 | 0.77059149 |
| 78 | PRKACG | 0.70945088 |
| 79 | CSK | 0.69269170 |
| 80 | SGK3 | 0.68352832 |
| 81 | STK16 | 0.68001220 |
| 82 | DDR2 | 0.65876521 |
| 83 | CDC42BPA | 0.63318344 |
| 84 | PRPF4B | 0.62925434 |
| 85 | TIE1 | 0.62243625 |
| 86 | TESK1 | 0.60072592 |
| 87 | CAMK1D | 0.58559975 |
| 88 | IRAK3 | 0.57178165 |
| 89 | MAPK12 | 0.56200355 |
| 90 | MAP4K2 | 0.56167804 |
| 91 | PDPK1 | 0.54461531 |
| 92 | TGFBR2 | 0.53320751 |
| 93 | AKT3 | 0.53137872 |
| 94 | SIK2 | 0.52161476 |
| 95 | HIPK2 | 0.51885314 |
| 96 | CAMK2G | 0.51560877 |
| 97 | NEK1 | 0.51437319 |
| 98 | MAP2K2 | 0.50379952 |
| 99 | STK39 | 0.49955906 |
| 100 | MTOR | 0.47662504 |
| 101 | SGK494 | 0.47440692 |
| 102 | SGK223 | 0.47440692 |
| 103 | EPHA3 | 0.47168050 |
| 104 | BMX | 0.47052932 |
| 105 | TAOK2 | 0.45505682 |
| 106 | CDK4 | 0.45401045 |
| 107 | FGFR3 | 0.44042855 |
| 108 | PIK3CA | 0.43643659 |
| 109 | CSF1R | 0.43535181 |
| 110 | MAPKAPK5 | 0.43414523 |
| 111 | MAP3K5 | 0.43198665 |
| 112 | MAP2K1 | 0.41559363 |
| 113 | IRAK4 | 0.41290791 |
| 114 | ARAF | 0.40479857 |
| 115 | CAMKK1 | 0.39685222 |
| 116 | EPHA2 | 0.39185471 |
| 117 | PRKCQ | 0.39062583 |
| 118 | SGK2 | 0.38839877 |
| 119 | STK38 | 0.38692209 |
| 120 | PDK1 | 0.38159626 |
| 121 | MUSK | 0.37350288 |
| 122 | IKBKE | 0.35774622 |
| 123 | MAP4K1 | 0.35710013 |
| 124 | MAPK7 | 0.35554750 |
| 125 | STK3 | 0.35009757 |
| 126 | MAP3K13 | 0.33826653 |
| 127 | IGF1R | 0.32544927 |
| 128 | IKBKB | 0.32420216 |
| 129 | EGFR | 0.31748114 |
| 130 | NEK2 | 0.31668912 |
| 131 | MAP3K8 | 0.31622792 |
| 132 | PRKG2 | 0.31423827 |
| 133 | GRK1 | 0.31365734 |
| 134 | MAP3K6 | 0.30736462 |
| 135 | RPS6KA6 | 0.29559460 |
| 136 | JAK3 | 0.28872995 |
| 137 | PRKD3 | 0.28324615 |
| 138 | EPHB2 | 0.27806973 |
| 139 | MAP3K1 | 0.26910234 |
| 140 | RPS6KL1 | 0.26868278 |
| 141 | RPS6KC1 | 0.26868278 |
| 142 | RPS6KB1 | 0.26641745 |
| 143 | FGR | 0.26557981 |
| 144 | RET | 0.26250572 |
| 145 | CHUK | 0.25766846 |
| 146 | MAPKAPK2 | 0.25763785 |
| 147 | CDK9 | 0.25250870 |
| 148 | BTK | 0.24679218 |
| 149 | MAP3K2 | 0.24572719 |
| 150 | CAMK4 | 0.24518223 |
| 151 | IRAK1 | 0.24206858 |
| 152 | PRKCA | 0.22455835 |
| 153 | PRKCG | 0.21480870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.18091279 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.45038794 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.39863814 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.24103356 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.96173835 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.69544810 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68221947 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58597718 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52900813 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48278966 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48229918 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41512654 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36976471 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21741361 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10488514 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09272064 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00861233 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90163260 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88443553 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87373083 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87188791 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83594139 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77540169 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70913934 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70161711 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69890514 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68834088 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64318139 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63080606 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62272139 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61980232 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60275292 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.59326647 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.57636889 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51126565 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47315881 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.45306867 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42934449 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40931089 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39414703 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31652909 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31155223 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29835987 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29744972 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29670814 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28259903 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27201607 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21726012 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15793939 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15283683 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.14723487 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14209493 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.13558184 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06378702 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04022645 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92563851 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91074916 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90347006 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.88703529 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87274062 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87099481 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86334274 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79198178 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77825741 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74244206 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70515209 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60969015 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60560674 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53256597 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52861095 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52472195 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49343415 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47485335 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41273341 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37791975 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30780316 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29064099 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.25519939 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.22994875 |
| 80 | Asthma_Homo sapiens_hsa05310 | 0.21758502 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21557957 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18076104 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17360990 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.15889345 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15473375 |
| 86 | Base excision repair_Homo sapiens_hsa03410 | 0.11962471 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11577288 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10603136 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.07556608 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04171385 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.03280512 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.01953767 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.00932661 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2416852 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2183641 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2147411 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1990031 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1964141 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | -0.1925613 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1716491 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | -0.1534839 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1475913 |
| 103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1330193 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1267773 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1120202 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1102753 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1093961 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0865680 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0781412 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0712397 |
| 111 | Lysosome_Homo sapiens_hsa04142 | -0.0192883 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0124062 |

